Company / Total Assets
Kymera Therapeutics, Inc. Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.7B
FY2025
5-year range
$575.8M / $1.7B
FY2021-FY2025
Trend
+78.2%
vs FY2024
Sector context
#45 of 214
Health Care
What the data says
Kymera Therapeutics, Inc.'s total assets of $1.7B is higher than 79% of companies in the Health Care sector (FY2025). Improved from $576M to $1.7B over the past 2 years.
Based on SEC 10-K filings.
$1.7B in FY2025 with a 5-year CAGR of +29.0%. Top quartile in the Health Care sector.
Improved from $576M to $1.7B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +42.4%
- 5-Year CAGR
- +29.0%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 214This company $1.7B Sector average $7.5B
▼
-76.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +29.0%, indicating consistent growth.
- In FY2025, total assets increased 78.2% year-over-year.
- Ranks #45 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.7B | +78.2% |
| FY2024 | $978.0M | +69.9% |
| FY2023 | $575.8M | -4.5% |
| FY2022 | $603.1M | -0.5% |
| FY2021 | $605.9M | +24.4% |
| FY2020 | $487.2M | +317.5% |
| FY2019 | $116.7M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026